Michael Cookson to Androgen Antagonists
This is a "connection" page, showing publications Michael Cookson has written about Androgen Antagonists.
Connection Strength
2.160
-
Castration-Resistant Prostate Cancer: An Algorithmic Approach. Urol Clin North Am. 2017 Nov; 44(4):647-655.
Score: 0.569
-
Castration-resistant prostate cancer: AUA Guideline. J Urol. 2013 Aug; 190(2):429-38.
Score: 0.417
-
Mechanisms leading to the development of hormone-resistant prostate cancer. Urol Clin North Am. 2006 May; 33(2):201-10, vii.
Score: 0.256
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. J Urol. 2021 Jan; 205(1):22-29.
Score: 0.174
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2021 Jan; 205(1):14-21.
Score: 0.174
-
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines. Prostate. 2020 05; 80(6):527-544.
Score: 0.167
-
Recent trends in the management of advanced prostate cancer. F1000Res. 2018; 7.
Score: 0.151
-
Hormonal therapy for metastatic prostate cancer: issues of timing and total androgen ablation. South Med J. 1994 Jan; 87(1):1-6.
Score: 0.109
-
Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability. Prostate. 2006 Aug 01; 66(11):1177-93.
Score: 0.065
-
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. Urology. 1997 Mar; 49(3A Suppl):46-55.
Score: 0.034
-
Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction. Urology. 1997 Mar; 49(3A Suppl):95-101.
Score: 0.034
-
Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology. 1997 Mar; 49(3A Suppl):113-8.
Score: 0.008